In China, although its total medical aesthetics industry is expected to clock in a total revenue of $ billion in 2019 and cosmetic surgery’s annual revenue will be $ billion and growing annually at 20%, the breast implant segment isn’t quite well received in China.
METHODOLOGY
To determine the market size of the plastic surgery specifically breast implant industry in China, we scoured through various reputable statistics and databases from industry reports, market research publications, government reports, annual reports, and news articles. As there was no available study or there was no release study yet that specifically discuss the breast implant procedure in China, we’ve utilised top-down analysis and methodology to come up with required data. All calculations, assumptions, and estimations made were detailed in the report.
FINDINGS
China’s Plastic Surgery Industry Market Size
The total cosmetic surgery industry in China was reportedly to generate $ billion annually and growing at 20% as of 2015.
2015: $ billion
2016: $ billion
2017: $ billion
2018: $ billion
2019: $ billion
2020: $ billion
Compared globally, the industry was valued at $ billion in 2016 and expected to reach $ billion by 2026, which translates to an annual growth rate of 5.75%.
Breast Implant Market Size
According to the latest published report by Reuters, the global breast implant will clock in a market size of $ billion by the end of 2025, from $ billion revenue in 2018. The market is expected to grow annually by % until 2025. Calculations are provided in the report.
2018: $ billion
2019: $ billion
2020: $ billion
2021: $ billion
2022: $ billion
2023: $ billion
2024: $ billion
2025: $ billion
The cosmetic surgery breast implant in Asia was valued at $ million in 2016 growing at % annually. Based from the analysis of the ratio provided in a report, China has an approximate market share of % in Asia, or an equivalent of $ million.
China’s cosmetic surgery breast implant market size in 2016 = $ million
The Persistence Market Research projected that China’s breast implant industry will reach $ million by 2025, which translates to a % annual growth rate.
2016 = $ million
2017 = $ million
2018 = $ million
2019 = $ million
2020 = $ million
2021 = $ million
2022 = $ million
2023 = $ million
2024 = $ million
2025 = $ million
Trends And Breast Implant Procedures in China
In China, although its total medical aesthetics industry is expected to clock in a total revenue of $ billion this 2019, breast implant/augmentation isn’t quite well received in China.
The medical aesthetic industry is composed mainly of Blepharoplasty (double eyelid surgery) and Rhinoplasty (heightening of nasal bridge), liposuction, nose lift, face lift, and wrinkle-removals. About 14 million Chinese (which was also reportedly expected to grow annually by %) go through plastic surgery annually, from just x million annual users in the previous years.
[Estimated number of breast implant procedures annually]
Calculations are provided in the report.
[Number of Plastic Surgery users in China]
Calculations are provided in the report.
In China, the most common method used by surgeons for breast implant is the use of soft silicone shells that are generally filled with silicone gel.
Number of clinics and average breast implant cost per procedure
While the average cost of breast implant procedure in China is around $, the cost of surgery using top-quality implants costs about N yuan. Most of the surgeries are done at private specialty clinics rather than large State-owned hospitals.
Top breast implant manufacturers, clinics, and hospitals
The four leading companies that dominated the global breast implant market are Allergan, Mentor Worldwide, GC Aesthetics, and Sientra. Other players include Arion Laboratories, Cereplas, Establishment Labs, Groupe Sebbin, Guangzhou Wanhe Plastic Materials, Hans Biomed, Ideal Implant, and Polytech Health and Aesthetics.
According to reports, Allergan itself holds % of the market or about $ million revenue every year for its breast implant products. Mentor Worldwide accounted for % and GC Aesthetics accounted for %. Sientra reported a $ million revenue on their breast implant products in 2017.
In Asia (which China holds the largest market share), the above top manufacturers also dominate the market. Although breast implants were reportedly done on private clinics than on hospitals, the top clinic who performs the most number of procedure cannot be determined in the country. The reason most likely due to illegal clinics operating and doing the procedure without proper registration, thus, no records of how many procedures were performed in each clinic and considering that there are only 2,800 registered plastic surgeons in the country.
In the hospital category, the top plastic surgery hospitals (who also offers breast implant surgery) are (provided in the report).
To buy this report, enter details below. We will reply and email you the report upon receipt of your order. Please give us a maximum 1-working days to process your order.
The Plastic Surgery And Breast Implants Market Size in China
Buy this report to understand your market and trends specifically in the Chinese market.
$4.95
